Mercy Research is looking for volunteers who have Type 2 Diabetes with risk factors of heart disease, or a family history of heart disease, who are willing to participate in a clinical trial. Participants will be educated and monitored for the safety and effectiveness of an investigational medication.
Type 2 Diabetes is a growing epidemic and is projected to affect 439 million people worldwide by 2030. People with Type 2 Diabetes have a higher risk of cardiovascular issues than patients without Type 2 Diabetes.
Qualified participants must be 18 years of age or older; be diagnosed with Type 2 Diabetes; have impaired kidney function; be willing to comply with study protocol; be willing to receive the investigational medication or placebo; and meet other required criteria.
“The medication we are trialing can potentially help those suffering from diabetes because it causes glucose to be excreted by the kidneys and the intestines,” said Mercy Dr. Vernon Leroy Young, principal investigator of the study. “Therefore, it could potentially also help patients suffering from kidney disease.”
Qualified participants will receive all study-related care at no cost. Compensation for time and travel may also be available. If you are interested in receiving more information about the study, please call 636-390-1452 or email MercyHealthResearch@Mercy.net.